The potential benefits of trilaciclib on blood product utilization and neutropenic fever episodes in small cell lung cancer patients: A propensity-matched cohort study.
Authors: Quaid Oza, Varada Salimath, Brittany Miles, James David Mackey
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e20134
Source:
Full article
Abstract
e20134